APA (7th ed.) Citation

Everaert, I., Van der Stede, T., Stautemas, J., Hanssens, M., van Aanhold, C., Baelde, H., . . . Derave, W. (2021). Oral anserine supplementation does not attenuate type-2 diabetes or diabetic nephropathy in BTBR ob/ob mice. Amino Acids, 53(8), 1269. https://doi.org/10.1007/s00726-021-03033-4

Chicago Style (17th ed.) Citation

Everaert, Inge, Thibaux Van der Stede, Jan Stautemas, Maxime Hanssens, Cleo van Aanhold, Hans Baelde, Lynn Vanhaecke, and Wim Derave. "Oral Anserine Supplementation Does Not Attenuate Type-2 Diabetes or Diabetic Nephropathy in BTBR Ob/ob Mice." Amino Acids 53, no. 8 (2021): 1269. https://doi.org/10.1007/s00726-021-03033-4.

MLA (9th ed.) Citation

Everaert, Inge, et al. "Oral Anserine Supplementation Does Not Attenuate Type-2 Diabetes or Diabetic Nephropathy in BTBR Ob/ob Mice." Amino Acids, vol. 53, no. 8, 2021, p. 1269, https://doi.org/10.1007/s00726-021-03033-4.